The share price is still very reasonable for someone to get into IPA, given the potential but window of opportunity is narrowing day by day. I am glad I was able to get into this company long time ago (2+ years). This COVID is obviously none of us dreamt about, who would have thought we would be in the middle of this pandemic. I was just happy with what they were doing as a CRO working with 60 percent of the 20 largest Pharma's. As tragic this is for people dying or suffering from the virus I am really happy that we are in the right sector at the right time. In a way it is good to know that this company has the potential to find the therapeutic cure. I believe there partnership with Janssens will hook them with J&J. J&J has significant funding coming from the US Government for the COVID vaccine. IPA will have everything researched and will just have to pass on the results to J&J for clinical trials and vaccine production.
News 
Market Data 
Discover 
